OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd, et al.
Life Sciences (2024) Vol. 348, pp. 122683-122683
Closed Access | Times Cited: 10

Showing 10 citing articles:

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8

Is there a place for engineered immune cell therapies in autoimmune diseases?
Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Trends in Molecular Medicine (2025)
Closed Access

Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors
Bo Zou, Mengge Wang, Shimeng Bai, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 844-844
Open Access

Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Mathan Muthu Chinakannu Marimuthu, Bhavani Sowndharya Balamurugan, Sundaram Vickram, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access

Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review
Chaozhi Tang, Yuling Zhang
Pathology - Research and Practice (2024) Vol. 262, pp. 155518-155518
Closed Access | Times Cited: 3

Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3

Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3

Page 1

Scroll to top